TORONTO, ON / ACCESSWIRE / November 29, 2021 / GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) (“GHP” or the “Company“), a Capital Pool Company listed on the TSX Venture Exchange, announces that Michael MacLachlan Franks has resigned as the Chief Executive Officer and as a director of the Company. Paul Barbeau, an existing director of the Company, has been appointed as Chief Executive Officer to fill the vacancy.
The Company also announces that all matters submitted to shareholders of the Company (the “Shareholders“) for approval at its annual general and special meeting held on October 12, 2021 were approved, including the following:
No date has been set for the proposed name change and consolidation that were approved at the Meeting. The Company will issue an additional news release if and when it determines to proceed with the name change and/or consolidation.
About GHP
GHP is a Capital Pool Company. Its principal business activity is to identify and evaluate opportunities to acquire assets or business. Incorporated under the laws of the Province of Ontario, GHP is a reporting issuer in the Provinces of British Columbia, Alberta and Ontario. Its Shares are listed for trading on the Exchange under the symbol PSYF.P.
For further information, please contact:
Paul Barbeau
CEO and Director
Phone: 613.777.2327
Email: paul@noeticfund.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: GHP Noetic Science-Psychedelic Pharma Inc.
View source version on accesswire.com:
https://www.accesswire.com/675168/GHP-Noetic-Science-Psychedelic-Pharma-Inc-Announces-Director-and-CEO-Change-Also-Announces-Results-of-2021-AGM
CHICAGO, IL / ACCESSWIRE / April 3, 2024 / The American College of Osteopathic Family…
Campaign underscores the urgency and need to support early career osteopathic family physicians.CHICAGO, IL /…
LAS VEGAS, NV / ACCESSWIRE / April 3, 2024 / Reveal Lasers, a burgeoning force…
Deeper integration unlocks powerful Weave features to improve patient experiencesLEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a…
CAMBRIDGE, MA / ACCESSWIRE / April 3, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that…
SOMERVILLE, NJ / ACCESSWIRE / April 3, 2024 / LPW Training Services, a global industry…